Do you want to read an article? Please log in or register.
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
Cardiovascular Risk and DiseasesLipid-Lowering Drugs
RECOMMENDED
Related content
Cardiovascular Risk and Diseases
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
BMJ.
Hippisley-Cox J, Coupland C, Brindle P
doi: 10.1136/bmj.j2099.
Cardiovascular Risk and Diseases
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
Lancet Glob Health.
WHO CVD Risk Chart Working Group.
doi: 10.1016/S2214-109X(19)30318-3.
RECOMMENDED
Cardiovascular Risk and Diseases
SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Eur Heart J
SCORE2-OP working group and ESC Cardiovascular risk collaboration .
doi: 10.1093/eurheartj/ehab312
RECOMMENDED
Cardiovascular Risk and Diseases
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies
Eur Heart J.
Pennells L, Kaptoge S, Wood A, Sweeting M, Zhao X, White I, Burgess S, Willeit P, Bolton T, Moons KGM, van der Schouw YT, Selmer R, Khaw KT, Gudnason V, Assmann G, Amouyel P, Salomaa V, Kivimaki M, Nordestgaard BG, Blaha MJ, Kuller LH, Brenner H, Gillum RF, Meisinger C, Ford I, Knuiman MW, Rosengren A, Lawlor DA, Völzke H, Cooper C, Marín Ibañez A, Casiglia E, Kauhanen J, Cooper JA, Rodriguez B, Sundström J, Barrett-Connor E, Dankner R, Nietert PJ, Davidson KW, Wallace RB, Blazer DG, Björkelund C, Donfrancesco C, Krumholz HM, Nissinen A, Davis BR, Coady S, Whincup PH, Jørgensen T, Ducimetiere P, Trevisan M, Engström G, Crespo CJ, Meade TW, Visser M, Kromhout D, Kiechl S, Daimon M, Price JF, Gómez de la Cámara A, Wouter Jukema J, Lamarche B, Onat A, Simons LA, Kavousi M, Ben-Shlomo Y, Gallacher J, Dekker JM, Arima H, Shara N, Tipping RW, Roussel R, Brunner EJ, Koenig W, Sakurai M, Pavlovic J, Gansevoort RT, Nagel D, Goldbourt U, Barr ELM, Palmieri L, Njølstad I, Sato S, Monique Verschuren WM, Varghese CV, Graham I, Onuma O, Greenland P, Woodward M, Ezzati M, Psaty BM, Sattar N, Jackson R, Ridker PM, Cook NR, D'Agostino RB Sr, Thompson SG, Danesh J, Di Angelantonio E; Emerging Risk Factors Collaboration
doi: 10.1093/eurheartj/ehy653.
RECOMMENDED
Cardiovascular Risk and Diseases
Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)
Eur Heart J Acute Cardiovasc Care.
Rossello X, Dorresteijn JA, Janssen A, Lambrinou E, Scherrenberg M, Bonnefoy-Cudraz E, Cobain M, Piepoli MF, Visseren FL, Dendale P
doi: 10.1177/2048872619858285.
Heart, Artery and Coronary DiseasesMyocardial InfarctionThrombosis and Stroke
Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection
Circulation.
Triant VA, Perez J, Regan S, Massaro JM, Meigs JB, Grinspoon SK, D'Agostino RB Sr.
doi: 10.1161/CIRCULATIONAHA.
Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases
Application of a Lifestyle-Based Tool to Estimate Premature Cardiovascular Disease Events in Young Adults: The Coronary Artery Risk Development in Young Adults (CARDIA) Study
JAMA Intern Med.
Gooding HC, Ning H, Gillman MW, Shay C, Allen N, Goff DC Jr, Lloyd-Jones D, Chiuve S
doi: 10.1001/
Cardiovascular Risk and DiseasesHeart, Artery and Coronary Diseases
Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator
Circulation.
Khera A, Budoff MJ, O'Donnell CJ, Ayers CA, Locke J, de Lemos JA, Massaro JM, McClelland RL, Taylor A, Levine BD
doi: 10.1161/CIRCULATIONAHA.
Cardiovascular Risk and Diseases
Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial
Eur Heart J.
de Vries TI, Eikelboom JW, Bosch J, Westerink J, Dorresteijn JAN, Alings M, Dyal L, Berkowitz SD, van der Graaf Y, Fox KAA, Visseren FLJ
doi: 10.1093/eurheartj/ehz404.